Dutch Firm TheOTCLab Gets EU MDR Approval For Dr. Yglo OTC Wart Device

Amsterdam-based TheOTCLab has received an EU CE mark for its new wart and verruca OTC freezing device Dr. Yglo. The firm plans to launch the product in Europe in Italy, Portugal, Estonia, Latvia, and Lithuania, and will separately look to take it further afield to the US and South Africa.

Amsterdam-based self-care company TheOTCLab Healthcare B.V. has received a European Union Medical Device Regulation certification for its latest OTC product, Dr. Yglo.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography